Jazz Venture Partners

Founded in 2015, Jazz Venture Partners is a venture capital firm based in San Francisco. It specializes in growth capital investments at the intersection of digital technology and neuroscience, focusing on augmented reality, artificial intelligence, immersive gaming, and closed-loop human-computer systems. The firm invests in companies operating in markets such as health, mind-body wellness, peak performance, learning, sports, and entertainment.

Stone Connell

Vice President of Finance

Sydney Cureton

Senior Associate

Sujude Dalieh

Senior Associate

Andrew Firlik

Managing Partner

Narie Foster

Venture Partner

John F. Harris

Managing Partner

Sharon Knight

Venture Partner

John Lee

Partner

Zack Lynch

Managing Partner

Justin Nuñez

Partner

Meghan Reynolds

Venture Partner

John Spinale

Managing Partner

Elan Tye

Principal

Allison Williams

Principal

82 past transactions

Justpoint

Series A in 2025
Justpoint is an artificial intelligence–driven platform that connects individuals seeking personal injury litigation with suitable attorneys. By applying predictive analytics, it assesses the merits of a claim and helps plaintiffs identify and retain lawyers best suited to their case, while enabling law firms to quickly find cases with merit. The platform also streamlines back-office tasks and discovery processes, improving efficiency for attorneys. With a broad network of more than 1,000 law firms and a database of hundreds of thousands of historical claims, Justpoint operates across 33 states to increase access to justice. The company combines expertise from legal, technical, and medical professionals to provide transparent, data-backed guidance throughout the litigation process.

KLOWEN Braces

Series B in 2024
KLOWEN Braces, Inc. specializes in the development of custom braces systems designed for orthodontists and their patients. Established in 2019 and headquartered in Fort Collins, Colorado, the company utilizes an innovative software platform to ensure the precise placement of uniquely shaped brackets for each tooth. KLOWEN Braces offers a range of orthodontic components, including modular brackets, hooks, bundles, tubes, and wires, all available through online channels. Its systems aim to provide a faster, more effective, and more comfortable alternative to traditional braces, enhancing the overall orthodontic treatment experience.

Pinpoint Predictive

Series A in 2024
Pinpoint Predictive develops a property and casualty insurance platform that delivers loss predictions and risk scores using basic data such as a name and address. The platform provides actuarial forecasts of claims frequency, severity, and loss cost, and generates risk scores that insurers can use at various points, including referrals, litigation, early cancellation, and preventing premium leakage. By enabling insurers to track consumers and tailor products from the outset of the customer journey, the company supports early risk selection and more personalized underwriting and pricing.

Enveda Biosciences

Series B in 2024
Enveda is a biotechnology company that uses AI-powered tools to explore and characterize molecules from living organisms. It aims to accelerate drug discovery by developing a comprehensive database of chemical biodiversity.

Bonito Biosciences

Seed Round in 2024
Bonito Biosciences is a biotechnology company focused on developing tissue-selective drug delivery systems for oligonucleotides and macromolecules. Their proprietary platform enables cell-specific delivery of RNA degraders, potentially improving the efficacy and safety of therapeutics for patients.

Transcripta Bio

Venture Round in 2024
Transcripta Bio, based in Palo Alto, California, specializes in pharmaceutical development using artificial intelligence. The company's core business involves generating new medicines for various diseases simultaneously, at an accelerated pace and with reduced risk. It offers services such as orchestrating gene expression, creating a drug-gene atlas, and predicting therapeutic genes, providing clients with a comprehensive view of genome-wide biological activity to aid in drug discovery.

Reken

Seed Round in 2024
Founded in 2024, Reken is an AI & cybersecurity company based in San Francisco. It specializes in developing innovative AI platforms and products designed to safeguard against emerging threats such as deepfake social engineering and automated fraud.

Tomato.ai

Seed Round in 2023
Tomato.ai is a technology company that specializes in enhancing voice communication for offshore agents. Its core product uses artificial intelligence to "soften" accents, improving intelligibility and trust during conversations. Additionally, Tomato.ai offers advanced noise cancellation solutions to ensure clear communication. The company's software aims to facilitate more efficient agent calls, enabling businesses to hire more offshore agents, increase sales, reduce churn, and improve overall job accessibility.

HerMD

Series A in 2023
HerMD is a Cincinnati‑based health and wellness company that offers a full range of services for women, including gynecology, menopause care, sexual medicine, obesity counseling, cervical screening, hormone therapy, and medical aesthetics such as facials and chemical peels. Founded in 2019 by Somi Javaid, the company aims to provide a safe, trusted environment for women to address both medical and aesthetic needs.

Robust.AI

Series A in 2023
Robust.AI develops autonomous mobile robots and AI-powered software for warehouse and manufacturing operations. The company combines artificial intelligence, robotics, and human-centered design through its Grace software suite and Carter hardware concept, enabling rapid deployment with minimal infrastructure changes, scalable operations, and support for dynamic material handling tasks. Its solutions target warehousing environments where automation is still limited and labor shortages affect supply chains, aiming to improve interaction between people and robots and to streamline workflows.

Zus Health

Series A in 2023
Zus Health is a healthcare technology company founded in 2020 by Jonathan Bush, based in Watertown, Massachusetts. It specializes in developing a healthcare data platform that accelerates the creation of digital health solutions. The platform uniquely integrates health and non-health information, allowing healthcare professionals to gain a comprehensive understanding of patients while sharing clinical and non-clinical data without requiring the same applications. By removing traditional barriers, Zus Health empowers a new generation of healthcare builders to design technologies and services that are more affordable and customizable, aiming to enhance the overall healthcare experience.

Cadence Neuroscience

Venture Round in 2023
Cadence Neuroscience develops implantable medical device therapies for epilepsy, central pain, and other neurological disorders. Founded in 2017 and based in Redmond, Washington, the company pursues core technology developed at Mayo Clinic that is being evaluated clinically. The device detects brain signals and delivers electrical stimulation to modulate neural circuits, enabling personalized brain stimulation to improve seizure control relative to existing protocols.

Revelata

Pre Seed Round in 2023
Revelata develops an artificial intelligence platform for extracting data from complex financial documents. Its product deepKPI automatically surfaces KPI time series buried within billions of pages of SEC filings. The platform automates discovery and extraction of structured information from unstructured long-form filings, enabling investors and investment professionals to streamline research and decision-making. Founded in 2020 and headquartered in Palo Alto, California.

Colossal Biosciences

Series B in 2023
Colossal Biosciences is a bioscience and genetic engineering company focused on restoring extinct species and protecting endangered ones. Leveraging gene editing technologies, including CRISPR, it pursues de-extinction initiatives such as reviving the woolly mammoth and aims to aid ecosystem restoration and biodiversity. The company develops technologies to revive species and repopulate ecosystems critical to environmental health and future human needs.

Enveda Biosciences

Series B in 2022
Enveda is a biotechnology company that uses AI-powered tools to explore and characterize molecules from living organisms. It aims to accelerate drug discovery by developing a comprehensive database of chemical biodiversity.

Form Bio

Series A in 2022
Form Bio is a biotechnology company specializing in AI-powered tools for accelerating adeno-associated virus (AAV) gene therapy development. Its platform offers predictive modeling, automated candidate optimization, and virtual biomanufacturing, serving researchers across various fields including lab directors, biotech, pharma, and academia.

Form Bio

Series A in 2022
Form Bio is a biotechnology company specializing in AI-powered tools for accelerating adeno-associated virus (AAV) gene therapy development. Its platform offers predictive modeling, automated candidate optimization, and virtual biomanufacturing, serving researchers across various fields including lab directors, biotech, pharma, and academia.

Foresight Mental Health

Series C in 2022
Foresight Mental Health is a technology-enabled psychiatry and therapy services company that directly employs psychiatrists, therapists, and psychiatric nurse practitioners to treat patients in its clinics. The company develops technology in collaboration with its providers, leveraging software and biomedical engineering to enhance care. Through a network of clinics, it offers a broad range of mental health treatments and wellness services and maintains patient profiles and a repository of scientific research and clinical information, including genetic profiles, comprehensive symptom profiles, and brain-chemical balance estimates to inform personalized care.

JobGet

Series B in 2022
JobGet Inc. is a mobile hiring application and job search platform based in Boston, Massachusetts, established in 2017. It serves as a marketplace connecting employers and job seekers, facilitating direct communication through messaging, scheduling meetings, and conducting video interviews. The platform is particularly focused on the retail and hospitality industries, significantly accelerating the job search process by reducing the timeline from weeks to mere minutes. JobGet has gained recognition as a top-rated application on both iOS and Android, assisting thousands of job seekers in engaging with prominent employers.

Oma Fertility

Venture Round in 2022
Oma Fertility is a comprehensive fertility clinic that provides a range of fertility care services, including in-vitro fertilization (IVF), egg freezing, embryo transfer, egg donation, sperm donation, and gestational surrogacy. The clinic utilizes advanced technologies, including artificial intelligence, to enhance the selection process of sperm cells for IVF through its proprietary AI microscope, Oma Sperm InSight. By integrating top lab design and technology with personalized care, Oma Fertility aims to make fertility treatments more accessible and affordable for a diverse population. The clinic also collaborates with external partners, such as surrogate agencies and egg and sperm banks, to facilitate a seamless experience for individuals and couples seeking fertility assistance.

Swing Therapeutics

Series A in 2022
Swing develops safe and effective digital therapeutics for chronic conditions, partnering with top researchers to create evidence-based treatments. Their solutions empower patients to manage their illnesses, improving health outcomes.

KLOWEN Braces

Series A in 2022
KLOWEN Braces, Inc. specializes in the development of custom braces systems designed for orthodontists and their patients. Established in 2019 and headquartered in Fort Collins, Colorado, the company utilizes an innovative software platform to ensure the precise placement of uniquely shaped brackets for each tooth. KLOWEN Braces offers a range of orthodontic components, including modular brackets, hooks, bundles, tubes, and wires, all available through online channels. Its systems aim to provide a faster, more effective, and more comfortable alternative to traditional braces, enhancing the overall orthodontic treatment experience.

Colossal Biosciences

Series A in 2022
Colossal Biosciences is a bioscience and genetic engineering company focused on restoring extinct species and protecting endangered ones. Leveraging gene editing technologies, including CRISPR, it pursues de-extinction initiatives such as reviving the woolly mammoth and aims to aid ecosystem restoration and biodiversity. The company develops technologies to revive species and repopulate ecosystems critical to environmental health and future human needs.

HerMD

Series A in 2022
HerMD is a Cincinnati‑based health and wellness company that offers a full range of services for women, including gynecology, menopause care, sexual medicine, obesity counseling, cervical screening, hormone therapy, and medical aesthetics such as facials and chemical peels. Founded in 2019 by Somi Javaid, the company aims to provide a safe, trusted environment for women to address both medical and aesthetic needs.

Augment AI

Seed Round in 2022
Augment AI enhances productivity by employing a context-aware artificial intelligence that learns user preferences and habits. It offers interactive assistants called Augments, which remember tasks, anticipate needs, and complete them across various apps.

Yumi

Series B in 2021
Yumi is a company that specializes in providing science-based meal delivery services for infants and young children. It focuses on producing fresh, nutrient-dense, and low-sugar baby food designed to meet the dietary needs of various age groups. Yumi aims to help parents understand the nutritional value of what they are feeding their children, particularly during the crucial early years of development. By offering a convenient and health-oriented solution, Yumi supports parents in ensuring their children receive optimal nutrition for brain development and overall well-being.

Sounding Board Labs

Series B in 2021
Founded in 2016, Sounding Board Labs develops a platform that provides personalized coaching for leaders and new managers. Its platform offers executive coaching, connects through phone, video, and chat, creates development plans, and provides surveys and reporting to track progress.

AppliedVR

Series B in 2021
AppliedVR is a Los Angeles‑based company that develops virtual reality therapeutic devices for pain and anxiety management in healthcare settings. Founded in 2013, it partners with institutions such as Cedars‑Sinai and Children’s Hospital Los Angeles to deliver its VR platform in hospitals, surgery centers, and exam rooms across the United States. The company’s flagship product, EaseVRx, is the first VR‑based prescription therapeutic to receive FDA Breakthrough Device Designation; it combines cognitive behavioral therapy and mindfulness to help patients alter pain perception and build coping skills. EaseVRx is self‑administered at home, enabling remote care and improving access, equity, and efficiency in chronic pain treatment. AppliedVR’s clinically validated, on‑demand platform supports both acute and chronic pain, promotes non‑drug pain management, and assists clinicians in achieving better long‑term patient outcomes.

Magnus Medical

Series A in 2021
Magnus Medical specializes in developing closed-loop neuromodulation technology for effectively treating intractable neurological and psychiatric disorders.

NextStep

Venture Round in 2021
NextStep is an information technology company based in Seattle, Washington, founded in 2018. It specializes in providing training and job placement services through a mobile application platform. The company's platform offers online certified nursing assistant (CNA) training and placement programs, as well as recruitment, training, and placement for various entry-level healthcare jobs such as community health workers, home health aides, and medical assistants. This enables individuals to quickly and affordably reskill themselves while helping employers in the healthcare sector find skilled employees.

Blue Note Therapeutics

Series A in 2021
Blue Note Therapeutics is a prescription digital therapeutics company that develops software-driven mental health solutions and collaborates with medical researchers and patient advocacy organizations to provide physician-prescribed therapies accessible on mobile devices. Its platform delivers evidence-based interventions designed to prevent, manage, and treat mental health conditions associated with serious illnesses, including cancer, and can be used as first-line or adjuvant therapies. The company is based in San Francisco, California, and was founded in 2018.

AllStripes

Series B in 2021
AllStripes is a healthcare technology company focused on accelerating the development of new treatments for rare diseases. The company has created a platform that enables the generation of regulatory-ready evidence, facilitating rare disease research and drug development. AllStripes operates a two-sided network that connects patients with rare diseases and advocacy groups to life science companies seeking new drug candidates. Through this network, patients can contribute their medical data and participate in treatment research online, while life science companies gain access to valuable data and insights to support their drug development efforts.

Mahana Therapeutics

Series B in 2021
Mahana Therapeutics, Inc. is a company focused on developing digital treatments for individuals with chronic health conditions, particularly gastrointestinal diseases. Its flagship offering, Parallel, is a clinically validated, minimal-contact digital program specifically designed for patients suffering from irritable bowel syndrome (IBS). The program aims to deliver both physical and psychological support to enhance patient well-being. Founded in 2018 and headquartered in San Francisco, California, Mahana Therapeutics also maintains an office in London, United Kingdom. The company was previously known as Mahana Health, Inc. before rebranding in July 2019.

Swing Therapeutics

Seed Round in 2021
Swing develops safe and effective digital therapeutics for chronic conditions, partnering with top researchers to create evidence-based treatments. Their solutions empower patients to manage their illnesses, improving health outcomes.

Woebot Health

Series B in 2021
Woebot Health is a digital mental healthcare provider that offers a platform designed to deliver personalized support and guidance. Utilizing advanced artificial intelligence and natural language processing, Woebot Health incorporates clinically proven therapeutic techniques into its services. The centerpiece of its offering is Woebot, an engaging relational agent that facilitates continuous, empathic, and user-friendly interactions. This innovative approach allows individuals and organizations to access effective mental health support seamlessly, fitting into daily life and providing help whenever needed. Woebot Health aims to enhance mental well-being through scalable digital tools, making mental health resources more accessible to a broad audience.

Intuition

Series A in 2021
Intuition is an AI-powered platform that offers employee engagement solutions.

Thrive Global

Series C in 2021
Thrive Global is a technology company founded in 2016 by Arianna Huffington. It offers a behavior change platform designed to improve well-being and performance through data-driven, actionable steps called Microsteps. The company serves individuals and corporations worldwide, aiming to end burnout culture and promote sustainable, science-based solutions for mental and physical health.

Zeitworks

Venture Round in 2021
Zeitworks Technologies, Inc., established in 2020 and headquartered in Seattle, Washington, with an additional office in Los Angeles, California, specializes in developing a SaaS platform for business process improvement. The platform employs machine learning to analyze and enhance customers' business processes, measuring execution step-by-step through the paths workers naturally take. It operates without disrupting users or requiring system integrations, making it currently available to select pilot customers.

Colossal Biosciences

Seed Round in 2021
Colossal Biosciences is a bioscience and genetic engineering company focused on restoring extinct species and protecting endangered ones. Leveraging gene editing technologies, including CRISPR, it pursues de-extinction initiatives such as reviving the woolly mammoth and aims to aid ecosystem restoration and biodiversity. The company develops technologies to revive species and repopulate ecosystems critical to environmental health and future human needs.

AppliedVR

Series A in 2021
AppliedVR is a Los Angeles‑based company that develops virtual reality therapeutic devices for pain and anxiety management in healthcare settings. Founded in 2013, it partners with institutions such as Cedars‑Sinai and Children’s Hospital Los Angeles to deliver its VR platform in hospitals, surgery centers, and exam rooms across the United States. The company’s flagship product, EaseVRx, is the first VR‑based prescription therapeutic to receive FDA Breakthrough Device Designation; it combines cognitive behavioral therapy and mindfulness to help patients alter pain perception and build coping skills. EaseVRx is self‑administered at home, enabling remote care and improving access, equity, and efficiency in chronic pain treatment. AppliedVR’s clinically validated, on‑demand platform supports both acute and chronic pain, promotes non‑drug pain management, and assists clinicians in achieving better long‑term patient outcomes.

Blue Note Therapeutics

Series A in 2021
Blue Note Therapeutics is a prescription digital therapeutics company that develops software-driven mental health solutions and collaborates with medical researchers and patient advocacy organizations to provide physician-prescribed therapies accessible on mobile devices. Its platform delivers evidence-based interventions designed to prevent, manage, and treat mental health conditions associated with serious illnesses, including cancer, and can be used as first-line or adjuvant therapies. The company is based in San Francisco, California, and was founded in 2018.

Outside

Series B in 2021
Outside operator of a digital media company planned to produce a collection of an active lifestyle and sports material. The company publishes lifestyle content such as storytelling, meal plans, gear reviews, online courses, films, TV series, discounted event access, magazines, and more across television, mobile, desktop, and print outlets from a variety of brands, allowing people to access a reliable website for endurance sports information.

Arrive Health

Series B in 2021
Arrive Health, founded in 2013 and based in Denver, Colorado, specializes in providing access to affordable, quality healthcare by delivering precise, patient-specific cost and coverage information. The company has developed integrated technologies that enhance health system workflows, enabling seamless communication among providers, care teams, and patients. Through its extensive network of payers, pharmacy benefit managers, and IT vendors, Arrive Health facilitates discussions about affordability and access by alerting healthcare professionals to coverage restrictions, lower-cost alternatives, and location-based care options. This helps providers make informed decisions, ultimately reducing friction throughout the care continuum.

NextStep

Venture Round in 2021
NextStep is an information technology company based in Seattle, Washington, founded in 2018. It specializes in providing training and job placement services through a mobile application platform. The company's platform offers online certified nursing assistant (CNA) training and placement programs, as well as recruitment, training, and placement for various entry-level healthcare jobs such as community health workers, home health aides, and medical assistants. This enables individuals to quickly and affordably reskill themselves while helping employers in the healthcare sector find skilled employees.

Pear Therapeutics

Series D in 2020
Pear Therapeutics, Inc. is a Boston-based commercial-stage healthcare company specializing in software-based digital therapeutics, also known as Prescription Digital Therapeutics (PDTs). Founded in 2013, the company develops clinically validated software solutions designed to treat a range of behavioral health disorders, including addiction, anxiety, depression, and chronic insomnia. Its suite of products includes mobile digital therapies that reward patients for engagement, and specific tools like reSET and reSET-O, aimed at treating substance use disorders. The company also offers Somryst, which provides neurobehavioral interventions for insomnia, and operates PearConnect, a patient services center that connects patients with advocates and resources, ensuring support throughout their treatment journey. Pear Therapeutics aims to enhance treatment outcomes by integrating digital therapies with pharmaceuticals and providing comprehensive support for patients, clinicians, and payors.

Genesis Therapeutics

Series A in 2020
Founded in 2019, Genesis Therapeutics is a biotechnology company based in South San Francisco, California. It specializes in developing small molecule drug candidates for treating debilitating disorders using artificial intelligence-driven platforms.

Robust.AI

Series A in 2020
Robust.AI develops autonomous mobile robots and AI-powered software for warehouse and manufacturing operations. The company combines artificial intelligence, robotics, and human-centered design through its Grace software suite and Carter hardware concept, enabling rapid deployment with minimal infrastructure changes, scalable operations, and support for dynamic material handling tasks. Its solutions target warehousing environments where automation is still limited and labor shortages affect supply chains, aiming to improve interaction between people and robots and to streamline workflows.

Freeletics

Series B in 2020
Freeletics is a digital fitness company that offers AI-powered fitness and mindset coaching through a mobile and web application. The platform provides personalized training programs, nutrition coaching, and workouts aimed at improving physical fitness and mental strength, with guidance designed to be accessible without equipment or gym access. Founded in 2013 and headquartered in Munich, Germany, Freeletics seeks to help individuals unleash their physical potential and confidence by delivering real-time health and lifestyle coaching.

Outside

Series A in 2020
Outside operator of a digital media company planned to produce a collection of an active lifestyle and sports material. The company publishes lifestyle content such as storytelling, meal plans, gear reviews, online courses, films, TV series, discounted event access, magazines, and more across television, mobile, desktop, and print outlets from a variety of brands, allowing people to access a reliable website for endurance sports information.

Zeitworks

Seed Round in 2020
Zeitworks Technologies, Inc., established in 2020 and headquartered in Seattle, Washington, with an additional office in Los Angeles, California, specializes in developing a SaaS platform for business process improvement. The platform employs machine learning to analyze and enhance customers' business processes, measuring execution step-by-step through the paths workers naturally take. It operates without disrupting users or requiring system integrations, making it currently available to select pilot customers.

The Meta

Series A in 2020
The Meta is an e-sports training platform for players of first-person shooter games. It applies sports performance science, game development techniques, and machine learning to help gamers improve skill, reach higher levels of competition, and climb ranks.

Mahana Therapeutics

Series A in 2020
Mahana Therapeutics, Inc. is a company focused on developing digital treatments for individuals with chronic health conditions, particularly gastrointestinal diseases. Its flagship offering, Parallel, is a clinically validated, minimal-contact digital program specifically designed for patients suffering from irritable bowel syndrome (IBS). The program aims to deliver both physical and psychological support to enhance patient well-being. Founded in 2018 and headquartered in San Francisco, California, Mahana Therapeutics also maintains an office in London, United Kingdom. The company was previously known as Mahana Health, Inc. before rebranding in July 2019.

NextStep

Venture Round in 2020
NextStep is an information technology company based in Seattle, Washington, founded in 2018. It specializes in providing training and job placement services through a mobile application platform. The company's platform offers online certified nursing assistant (CNA) training and placement programs, as well as recruitment, training, and placement for various entry-level healthcare jobs such as community health workers, home health aides, and medical assistants. This enables individuals to quickly and affordably reskill themselves while helping employers in the healthcare sector find skilled employees.

Mahana Therapeutics

Seed Round in 2020
Mahana Therapeutics, Inc. is a company focused on developing digital treatments for individuals with chronic health conditions, particularly gastrointestinal diseases. Its flagship offering, Parallel, is a clinically validated, minimal-contact digital program specifically designed for patients suffering from irritable bowel syndrome (IBS). The program aims to deliver both physical and psychological support to enhance patient well-being. Founded in 2018 and headquartered in San Francisco, California, Mahana Therapeutics also maintains an office in London, United Kingdom. The company was previously known as Mahana Health, Inc. before rebranding in July 2019.

Cadence Neuroscience

Series A in 2019
Cadence Neuroscience develops implantable medical device therapies for epilepsy, central pain, and other neurological disorders. Founded in 2017 and based in Redmond, Washington, the company pursues core technology developed at Mayo Clinic that is being evaluated clinically. The device detects brain signals and delivers electrical stimulation to modulate neural circuits, enabling personalized brain stimulation to improve seizure control relative to existing protocols.

NextStep

Series A in 2019
NextStep is an information technology company based in Seattle, Washington, founded in 2018. It specializes in providing training and job placement services through a mobile application platform. The company's platform offers online certified nursing assistant (CNA) training and placement programs, as well as recruitment, training, and placement for various entry-level healthcare jobs such as community health workers, home health aides, and medical assistants. This enables individuals to quickly and affordably reskill themselves while helping employers in the healthcare sector find skilled employees.

Arrive Health

Series A in 2019
Arrive Health, founded in 2013 and based in Denver, Colorado, specializes in providing access to affordable, quality healthcare by delivering precise, patient-specific cost and coverage information. The company has developed integrated technologies that enhance health system workflows, enabling seamless communication among providers, care teams, and patients. Through its extensive network of payers, pharmacy benefit managers, and IT vendors, Arrive Health facilitates discussions about affordability and access by alerting healthcare professionals to coverage restrictions, lower-cost alternatives, and location-based care options. This helps providers make informed decisions, ultimately reducing friction throughout the care continuum.

Wade & Wendy

Series A in 2019
Wade & Wendy, Inc. is a New York-based company that specializes in enhancing the hiring process through artificial intelligence. Founded in June 2015 by Josh Brandoff, Adrian von der Osten, and Drew Austin, the company develops two primary chatbots: Wendy, which assists employers by screening applicants on career websites and making hiring recommendations, and Wade, which supports job seekers by recording their data and identifying suitable job opportunities. The platform leverages machine intelligence and big data to provide insights that facilitate more informed hiring decisions, fostering a more engaging and human-centric recruitment experience for both job seekers and hiring teams.

Pear Therapeutics

Series C in 2019
Pear Therapeutics, Inc. is a Boston-based commercial-stage healthcare company specializing in software-based digital therapeutics, also known as Prescription Digital Therapeutics (PDTs). Founded in 2013, the company develops clinically validated software solutions designed to treat a range of behavioral health disorders, including addiction, anxiety, depression, and chronic insomnia. Its suite of products includes mobile digital therapies that reward patients for engagement, and specific tools like reSET and reSET-O, aimed at treating substance use disorders. The company also offers Somryst, which provides neurobehavioral interventions for insomnia, and operates PearConnect, a patient services center that connects patients with advocates and resources, ensuring support throughout their treatment journey. Pear Therapeutics aims to enhance treatment outcomes by integrating digital therapies with pharmaceuticals and providing comprehensive support for patients, clinicians, and payors.

AI Redefined

Seed Round in 2018
AI Redefined is a software company focused on advancing human-AI collaboration through machine learning research and open-source tooling. It provides a platform and infrastructure that enables continuous live training of AIs and humans in the same environment, supporting industries such as aeronautics, renewable energy, manufacturing, and autonomous systems. Its flagship framework, Cogment, is a high-performance open-source tool for multi-agent, multi-reward training in live environments. The company aims to create a universal, safe digital space where people and AIs learn from each other, leveraging features like operator AI apprentice, adaptive learning, and fine-tuning to accelerate practical adoption and frictionless collaboration between humans and machines.

Freeletics

Series A in 2018
Freeletics is a digital fitness company that offers AI-powered fitness and mindset coaching through a mobile and web application. The platform provides personalized training programs, nutrition coaching, and workouts aimed at improving physical fitness and mental strength, with guidance designed to be accessible without equipment or gym access. Founded in 2013 and headquartered in Munich, Germany, Freeletics seeks to help individuals unleash their physical potential and confidence by delivering real-time health and lifestyle coaching.

NextStep

Seed Round in 2018
NextStep is an information technology company based in Seattle, Washington, founded in 2018. It specializes in providing training and job placement services through a mobile application platform. The company's platform offers online certified nursing assistant (CNA) training and placement programs, as well as recruitment, training, and placement for various entry-level healthcare jobs such as community health workers, home health aides, and medical assistants. This enables individuals to quickly and affordably reskill themselves while helping employers in the healthcare sector find skilled employees.

Perceptive Automata

Series A in 2018
Perceptive Automata, Inc. is a technology company specializing in machine learning and computer vision solutions aimed at predicting human behavior in the context of automated driving. Founded in 2014 and located in Somerville, Massachusetts, the company addresses the complex challenges associated with the safe deployment of highly automated and fully autonomous vehicles, particularly in urban settings. Its advanced AI inference models allow vehicles to anticipate the actions of pedestrians, cyclists, and other drivers, enhancing safety and enabling smoother navigation in human-dominated environments. By integrating its software into autonomous driving systems, Perceptive Automata facilitates a more natural driving experience, which is crucial for the acceptance of autonomous vehicles and robotaxi services. The company's team comprises experts from prestigious institutions such as Harvard, MIT, and Stanford, reflecting a strong foundation in neuroscience and artificial intelligence.

Pymetrics

Series B in 2018
Pymetrics, Inc. is a company that specializes in neuroscience-based assessment and prediction technology aimed at transforming hiring, retention, and employee development processes. Founded in 2013 and headquartered in New York City, Pymetrics offers solutions that combine cognitive and emotional assessments with a dynamic recommendation engine. This platform utilizes artificial intelligence and machine learning to analyze behavioral data collected from successful professionals across various roles, helping organizations identify key traits that differentiate high performers from the general population. By focusing on improving the recruitment process, Pymetrics aims to enhance accuracy and reduce bias in hiring decisions.

Freeletics

Venture Round in 2018
Freeletics is a digital fitness company that offers AI-powered fitness and mindset coaching through a mobile and web application. The platform provides personalized training programs, nutrition coaching, and workouts aimed at improving physical fitness and mental strength, with guidance designed to be accessible without equipment or gym access. Founded in 2013 and headquartered in Munich, Germany, Freeletics seeks to help individuals unleash their physical potential and confidence by delivering real-time health and lifestyle coaching.

Embodied

Series A in 2018
Embodied, Inc. is a robotics company based in Pasadena, California, specializing in the development of personal companion robots aimed at enhancing care and wellness. Founded in 2016 and formerly known as CareBots, Inc., the company has created Moxie, an interactive robot designed for children that promotes social, emotional, and cognitive development through play-based learning. Drawing on over 14 years of research in socially assistive robotics from the University of Southern California and extensive experience in consumer robotics, Embodied combines advanced artificial intelligence with engaging storytelling and animation techniques. The company's mission is to improve the quality of life for individuals and families by providing life-like, interactive robots that serve as motivators, coaches, and companions, empowering users to improve their own well-being.

Wisdo Health

Convertible Note in 2018
Wisdo Health is an AI-powered social health platform that uses data and meaningful connections to support health and well-being. The service addresses loneliness and social isolation by enabling users to stay connected, share experiences, and access personalized health guidance and clinical referrals. By fostering peer support and information exchange, Wisdo Health aims to improve mental and physical health outcomes while helping reduce medical costs. The platform emphasizes ongoing engagement, using user-generated insights to inform care and enable measurable health improvements through community-driven support and access to professional resources.

Thrive Global

Series B in 2018
Thrive Global is a technology company founded in 2016 by Arianna Huffington. It offers a behavior change platform designed to improve well-being and performance through data-driven, actionable steps called Microsteps. The company serves individuals and corporations worldwide, aiming to end burnout culture and promote sustainable, science-based solutions for mental and physical health.

Akili Interactive

Series C in 2018
Akili Interactive Labs, Inc., established in 2011 and headquartered in Boston, Massachusetts, specializes in developing digital medicine solutions. The company's core business involves creating video game-based technology to assess and enhance cognitive abilities. Akili's broad pipeline focuses on treating cognitive deficiencies and improving symptoms associated with various medical conditions, such as ADHD, MDD, ASD, and inflammatory diseases.

Woebot Health

Series A in 2018
Woebot Health is a digital mental healthcare provider that offers a platform designed to deliver personalized support and guidance. Utilizing advanced artificial intelligence and natural language processing, Woebot Health incorporates clinically proven therapeutic techniques into its services. The centerpiece of its offering is Woebot, an engaging relational agent that facilitates continuous, empathic, and user-friendly interactions. This innovative approach allows individuals and organizations to access effective mental health support seamlessly, fitting into daily life and providing help whenever needed. Woebot Health aims to enhance mental well-being through scalable digital tools, making mental health resources more accessible to a broad audience.

Halo Neuro

Series B in 2018
Halo Neuro, established in 2013 and headquartered in San Francisco, specializes in developing neurotechnology systems. Its flagship product, Halo Sport, employs a technique called Neuropriming, which combines electrical stimulation with movement-based training to enhance skill and strength acquisition in elite athletes. This process temporarily boosts the brain's learning capacity, or 'hyperplasticity', refining its ability to adapt to training. The company aims to help individuals unlock their full potential through innovative brain stimulation technology.

Pear Therapeutics

Series B in 2018
Pear Therapeutics, Inc. is a Boston-based commercial-stage healthcare company specializing in software-based digital therapeutics, also known as Prescription Digital Therapeutics (PDTs). Founded in 2013, the company develops clinically validated software solutions designed to treat a range of behavioral health disorders, including addiction, anxiety, depression, and chronic insomnia. Its suite of products includes mobile digital therapies that reward patients for engagement, and specific tools like reSET and reSET-O, aimed at treating substance use disorders. The company also offers Somryst, which provides neurobehavioral interventions for insomnia, and operates PearConnect, a patient services center that connects patients with advocates and resources, ensuring support throughout their treatment journey. Pear Therapeutics aims to enhance treatment outcomes by integrating digital therapies with pharmaceuticals and providing comprehensive support for patients, clinicians, and payors.

Level Ex

Series A in 2017
Level Ex, Inc. is a Chicago-based company that specializes in developing virtual surgery mobile applications and professional medical video games aimed at physicians. Founded in 2015, the company focuses on enhancing surgical training through innovative platforms, such as Virtual Technique Guides, which leverage multiplayer interactivity to facilitate virtual procedures in collaboration with medical device representatives. One of its notable products, Airway EX, is designed to help physicians master critical skills in endoscopic and interventional airway procedures, addressing various medical challenges such as obstructing tumors and complex intubations. By employing advanced video game technology and cognitive neuroscience, Level Ex enables healthcare professionals to stay current with rare cases, new medical devices, and evolving drug therapies, ultimately improving their surgical capabilities and decision-making skills.

Pymetrics

Series A in 2017
Pymetrics, Inc. is a company that specializes in neuroscience-based assessment and prediction technology aimed at transforming hiring, retention, and employee development processes. Founded in 2013 and headquartered in New York City, Pymetrics offers solutions that combine cognitive and emotional assessments with a dynamic recommendation engine. This platform utilizes artificial intelligence and machine learning to analyze behavioral data collected from successful professionals across various roles, helping organizations identify key traits that differentiate high performers from the general population. By focusing on improving the recruitment process, Pymetrics aims to enhance accuracy and reduce bias in hiring decisions.

Augment CXM

Seed Round in 2017
Augment CXM is a pioneering company in the customer experience management sector, utilizing a patented semantic neural network to enhance customer interactions. The company develops an advanced platform that aids customer service agents by providing real-time monitoring of digital and voice communications, offering actionable insights to improve key performance indicators. This innovative approach has demonstrated significant results for its clients, including a 30% increase in agent efficiency, a 44% boost in sales conversion rates, and a 40% rise in customer satisfaction. Augment CXM serves a diverse range of prominent brands, positioning itself as a leader in transforming the customer experience landscape through artificial intelligence-driven solutions.

Aira

Series B in 2017
Aira offers on-demand visual interpretation services for individuals who are blind or have low vision. Users can access trained professionals via a mobile app, enabling them to navigate daily tasks more independently.

Two Bit Circus

Series B in 2017
Two Bit Circus, Inc. is an entertainment company based in Los Angeles, California, founded in 2012. It specializes in creating and operating micro-amusement parks that blend modern interactive technology with the classic charm of circus and carnival experiences. These one-acre venues are designed to provide unique recreational opportunities, featuring immersive games, interactive amusements, stage shows, and food offerings. The company also runs a Park as a Platform program that allows game developers to create location-based entertainment. In addition to its physical installations, Two Bit Circus sells merchandise online, including T-shirts and stickers. The company is committed to fostering community engagement and innovation through its nonprofit arm, the Two Bit Circus Foundation, which promotes STEAM education and access to maker tools for schools and youth.

Halo Neuro

Series A in 2016
Halo Neuro, established in 2013 and headquartered in San Francisco, specializes in developing neurotechnology systems. Its flagship product, Halo Sport, employs a technique called Neuropriming, which combines electrical stimulation with movement-based training to enhance skill and strength acquisition in elite athletes. This process temporarily boosts the brain's learning capacity, or 'hyperplasticity', refining its ability to adapt to training. The company aims to help individuals unlock their full potential through innovative brain stimulation technology.

Pear Therapeutics

Series A in 2016
Pear Therapeutics, Inc. is a Boston-based commercial-stage healthcare company specializing in software-based digital therapeutics, also known as Prescription Digital Therapeutics (PDTs). Founded in 2013, the company develops clinically validated software solutions designed to treat a range of behavioral health disorders, including addiction, anxiety, depression, and chronic insomnia. Its suite of products includes mobile digital therapies that reward patients for engagement, and specific tools like reSET and reSET-O, aimed at treating substance use disorders. The company also offers Somryst, which provides neurobehavioral interventions for insomnia, and operates PearConnect, a patient services center that connects patients with advocates and resources, ensuring support throughout their treatment journey. Pear Therapeutics aims to enhance treatment outcomes by integrating digital therapies with pharmaceuticals and providing comprehensive support for patients, clinicians, and payors.

Akili Interactive

Series B in 2016
Akili Interactive Labs, Inc., established in 2011 and headquartered in Boston, Massachusetts, specializes in developing digital medicine solutions. The company's core business involves creating video game-based technology to assess and enhance cognitive abilities. Akili's broad pipeline focuses on treating cognitive deficiencies and improving symptoms associated with various medical conditions, such as ADHD, MDD, ASD, and inflammatory diseases.

Level Ex

Seed Round in 2016
Level Ex, Inc. is a Chicago-based company that specializes in developing virtual surgery mobile applications and professional medical video games aimed at physicians. Founded in 2015, the company focuses on enhancing surgical training through innovative platforms, such as Virtual Technique Guides, which leverage multiplayer interactivity to facilitate virtual procedures in collaboration with medical device representatives. One of its notable products, Airway EX, is designed to help physicians master critical skills in endoscopic and interventional airway procedures, addressing various medical challenges such as obstructing tumors and complex intubations. By employing advanced video game technology and cognitive neuroscience, Level Ex enables healthcare professionals to stay current with rare cases, new medical devices, and evolving drug therapies, ultimately improving their surgical capabilities and decision-making skills.

Eyefluence

Series B in 2015
Eyefluence, Inc. is a technology company specializing in eye-interaction solutions for augmented reality (AR), virtual reality (VR), and mixed reality (MR) head-mounted displays (HMDs). Founded in 2013 and headquartered in Reno, Nevada, Eyefluence integrates its innovative technology with HMDs to enable users to control devices through eye movements, leveraging insights from eye biomechanics and the eye-brain connection. This approach allows for a natural and intuitive interaction, enhancing user experiences in the AR, VR, and MR environments. The company boasts a robust intellectual property portfolio with over 30 patents granted or pending, reflecting its commitment to advancing eye-tracking technology. Led by experienced entrepreneurs, Eyefluence collaborates with both startups and established enterprises to promote the adoption of smart glasses across various sectors, including consumer, industrial, and government applications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.